Join, share, learn and collaborate 48 leading life science organisations, and growing. Celebrating 12 Years Shaping the Future of Pharmacovigilance
Big Pharma's financial aspiration has been ever present but, 20 years ago, it lived in a more harmonious balance with the desire to save and improve lives. Many of us in the industry still aspire to help people through the development and application of science; but, for most of us, our contexts and the investment decisions are ultimately driven by the numbers. With this in mind, Nostrapharmus asks: what about the minor league, those unmet medical needs, with unattractive financial prospects?
If you would like to read the article in full, please click on the pdf link below:
About Pharma magazine